Mathurin Fumery

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2023

LINKED CONTENT This article is linked to Volkers et al papers. To view these articles, visit https://doi.org/10.1111/apt.17153 and https://doi.org/10.1111/apt.17407

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (6)

Rupert Leong

Professor of Medicine (Conjoint)

The University of Sydney School of Medicine

AUSTRALIA

View details

Nicolas Richard

University of Rouen

FRANCE

View details

Stéphane Paul

Université Claude Bernard Lyon 1

FRANCE

View details

Anthony Buisson

FRANCE

View details

Axel Dignass

Goethe University Frankfurt

GERMANY

View details

Ariane LEROYER

Université de Lille

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mathurin Fumery

Research Interests

Explore related searches

Contact this professor

Articles (9)

Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease

Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in patients with inflammatory bowel disease

Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study

Editorial: golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring—author's reply

Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study

Editorial: risankizumab – ready to break ceilings? author's reply

Real‐world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti‐TNF agent

Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study

Letter: treatment with subcutaneous CT‐P13 in Crohn’s disease patients with intravenous infliximab failure

Collaborators (6)

Rupert Leong

Nicolas Richard

Stéphane Paul

Anthony Buisson

Axel Dignass

Ariane LEROYER

Make your next move.